Cilfa Opposition, Sglt1 Inhibitor, (Ar098670 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098982A1)
Countries: Argentina Date: 2016
-
CILFA opposition, MELOXICAM, (AR100293A2)
Countries: Argentina Date: 2016
-
CILFA opposition, Aclidinium, (AR095705A1)
Countries: Argentina Date: 2016
-
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098983A1)
Countries: Argentina Date: 2016
-
CILFA opposition, aripiprazole, (AR098808A2)
Countries: Argentina Date: 2016
-
CILFA opposition, Atazanavir / cobicistat, (AR099119A1)
Countries: Argentina Date: 2016
-
CILFA opposition, Ezetimibe and Rosuvastatin, (AR098996A1)
Countries: Argentina Date: 2016
-
CILFA opposition, SALMETEROL, (AR098867A1)
Countries: Argentina Date: 2016
-
CILFA opposition, aripiprazole, (AR096131A1)
Countries: Argentina Date: 2016
-
CILFA opposition, necrostatine-1, (AR098778A1)
Countries: Argentina Date: 2016